Meningococcal Quadrivalent Vaccines

9 months to 55 years-old

Menactra

 Provider:

SANOFI (賽諾菲)

Certification:

FDA & Hong Kong Department of Health

Suggested age:

9 months to 55 years-old

Disease Prevention:

Meningococcal quadrivalent vaccines protect against 4 types of meningococcal bacteria: types A, C, Y and W-135.

Side Effect:

Soreness, redness and swelling where the vaccine was given.

Interval:

9 - 23 months old: 2 dose, 3 months minimum interval
2-55 years old: 1 dose

Meningococcal Quadrivalent Vaccines

Precautions:

/